CVS Health Corporation (CVS)
NYSE: CVS · IEX Real-Time Price · USD
68.60
-0.43 (-0.62%)
At close: Apr 17, 2024, 4:00 PM
68.66
+0.06 (0.09%)
Pre-market: Apr 18, 2024, 4:02 AM EDT

CVS Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Net Income
8,3444,3118,0017,1796,634-5946,6225,3175,2374,644
Upgrade
Depreciation & Amortization
0004,4414,3712,7182,4792,4752,0921,931
Upgrade
Share-Based Compensation
000400453280234222230165
Upgrade
Other Operating Activities
5,08211,86610,2643,8451,3906,461-1,3282,1279801,397
Upgrade
Operating Cash Flow
13,42616,17718,26515,86512,8488,8658,00710,1418,5398,137
Upgrade
Operating Cash Flow Growth
-17.01%-11.43%15.13%23.48%44.93%10.72%-21.04%18.76%4.94%40.71%
Upgrade
Capital Expenditures
-3,031-2,727-2,520-2,437-2,457-2,037-1,918-2,224-2,332-2,125
Upgrade
Acquisitions
-16,612-1,388-146-26-444-41,394-1,181-524-11,475-2,439
Upgrade
Change in Investments
-1,314-1,017-2,717-3,071-480125189241387519
Upgrade
Other Investing Activities
6885122-42213337--
Upgrade
Investing Cash Flow
-20,889-5,047-5,261-5,534-3,339-43,285-2,877-2,470-13,420-4,045
Upgrade
Dividends Paid
-3,132-2,907-2,625-2,624-2,603-2,038-2,049-1,840-1,576-1,288
Upgrade
Share Issuance / Repurchase
-1,735-2,949549264210242-4,032-4,165-4,639-3,580
Upgrade
Debt Issued / Paid
7,932-4,211-9,267-5,673-5,32038,265-598-61411,218-932
Upgrade
Other Financing Activities
-382-449-1333759350-72-142-124106
Upgrade
Financing Cash Flow
2,683-10,516-11,356-7,696-7,65436,819-6,751-6,7614,879-5,694
Upgrade
Exchange Rate Effect
00000-412-20-6
Upgrade
Net Cash Flow
-4,7806141,6482,6351,8552,395-1,620912-22-1,608
Upgrade
Free Cash Flow
10,39513,45015,74513,42810,3916,8286,0897,9176,2076,012
Upgrade
Free Cash Flow Growth
-22.71%-14.58%17.25%29.23%52.18%12.14%-23.09%27.55%3.24%56.03%
Upgrade
Free Cash Flow Margin
2.91%4.17%5.39%5.00%4.05%3.51%3.30%4.46%4.05%4.31%
Upgrade
Free Cash Flow Per Share
8.0910.2511.9410.267.996.545.977.385.555.18
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).